Targeted cancer therapy focuses on specific molecular targets associated with cancer growth and progression. These therapies are designed to attack cancer cells while minimizing damage to healthy tissues, offering improved efficacy and safety compared to conventional chemotherapy.

Medicina Overseas supplies a comprehensive range of targeted therapy medicines including tyrosine kinase inhibitors (TKIs), monoclonal antibodies, and small-molecule inhibitors used in the treatment of lung cancer, breast cancer, colorectal cancer, leukemia, and other advanced malignancies.

We provide high-quality targeted cancer medicines for patients, hospitals, and global distributors, with complete export documentation and reliable international delivery.